Ozempic Lawsuit 2025: Settlement Amounts, Criteria, and MDL Updates for Patients
As of August 2025, the Ozempic lawsuit is rapidly expanding—federal filings in the GLP-1 MDL have surged past 2,190 claims, and emerging vision loss suits alleging NAION-related harm are being consolidated in state courts. At the same time, Novo Nordisk has launched legal action against compounding pharmacies producing unauthorized semaglutide—efforts that follow a judge’s recent … Read more